SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015654
Filing Date
2021-11-12
Accepted
2021-11-12 07:58:03
Documents
81
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20210930x10q.htm   iXBRL 10-Q 2210203
2 EX-31.1 aplt-20210930xex31d1.htm EX-31.1 9686
3 EX-31.2 aplt-20210930xex31d2.htm EX-31.2 9679
4 EX-32.1 aplt-20210930xex32d1.htm EX-32.1 6286
5 EX-32.2 aplt-20210930xex32d2.htm EX-32.2 5930
  Complete submission text file 0001558370-21-015654.txt   8279380

Data Files

Seq Description Document Type Size
6 EX-101.SCH aplt-20210930.xsd EX-101.SCH 59155
7 EX-101.CAL aplt-20210930_cal.xml EX-101.CAL 56389
8 EX-101.DEF aplt-20210930_def.xml EX-101.DEF 228432
9 EX-101.LAB aplt-20210930_lab.xml EX-101.LAB 490737
10 EX-101.PRE aplt-20210930_pre.xml EX-101.PRE 395423
11 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20210930x10q_htm.xml XML 1420452
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 211399671
SIC: 2834 Pharmaceutical Preparations